Literature DB >> 30753137

Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.

Antonio M Lerario1, Kazutaka Nanba2, Amy R Blinder2, Sachiko Suematsu3, Masao Omura4, Tetsuo Nishikawa3, Thomas J Giordano1,5,6, William E Rainey1,2, Tobias Else1.   

Abstract

Somatic variants in genes that regulate intracellular ion homeostasis have been identified in aldosterone-producing adenomas (APA). Although the mechanisms leading to an increased aldosterone production in APA cells has been well studied, the molecular events that cause cell proliferation and tumor formation are poorly understood. In the present study, we have performed whole exome sequencing (WES) to characterize the landscape of somatic alterations in a homogeneous series of APA with pathogenic KCNJ5 variants. In the WES analysis on eleven APA, 84 exonic somatic events were called by 3 different somatic callers. Besides the KCNJ5 gene, only two genes (MED13 and ZNF669) harbored somatic variants in more than one APA. Unlike adrenocortical carcinomas, no chromosomal instability was observed by the somatic copy-number alteration and loss of heterozygosity analyses. The estimated tumor purity ranged from 0.35 to 0.67, suggesting a significant proportion of normal cell infiltration. Based on the results of PureCN analysis, the KCNJ5 variants appear to be clonal. In conclusion, in addition to KCNJ5 somatic pathogenic variant, no significant somatic event that would obviously explain proliferation or tumor growth was observed in our homogeneous cohort of KCNJ5-mutated APA. The molecular mechanisms causing APA growth and tumorigenesis remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30753137      PMCID: PMC7869655          DOI: 10.1530/ERC-18-0364

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  42 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

3.  Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?

Authors:  T Dekkers; M ter Meer; J W M Lenders; A R M Hermus; L Schultze Kool; J F Langenhuijsen; K Nishimoto; T Ogishima; K Mukai; E A B Azizan; B Tops; J Deinum; B Küsters
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

4.  KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.

Authors:  Paolo Mulatero; Philipp Tauber; Maria-Christina Zennaro; Silvia Monticone; Katharina Lang; Felix Beuschlein; Evelyn Fischer; Davide Tizzani; Anna Pallauf; Andrea Viola; Laurence Amar; Tracy Ann Williams; Tim M Strom; Elisabeth Graf; Sascha Bandulik; David Penton; Pierre-François Plouin; Richard Warth; Bruno Allolio; Xavier Jeunemaitre; Franco Veglio; Martin Reincke
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

5.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Authors:  Frédérique Tissier; Catherine Cavard; Lionel Groussin; Karine Perlemoine; Gwladys Fumey; Anne-Marie Hagneré; Fernande René-Corail; Eric Jullian; Christine Gicquel; Xavier Bertagna; Marie-Cécile Vacher-Lavenu; Christine Perret; Jérôme Bertherat
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

6.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

Review 7.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

9.  Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data.

Authors:  Konstantin Okonechnikov; Ana Conesa; Fernando García-Alcalde
Journal:  Bioinformatics       Date:  2015-10-01       Impact factor: 6.937

10.  Activating mutations in CTNNB1 in aldosterone producing adenomas.

Authors:  Tobias Åkerström; Rajani Maharjan; Holger Sven Willenberg; Kenko Cupisti; Julian Ip; Ana Moser; Peter Stålberg; Bruce Robinson; K Alexander Iwen; Henning Dralle; Martin K Walz; Hendrik Lehnert; Stan Sidhu; Celso Gomez-Sanchez; Per Hellman; Peyman Björklund
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

View more
  3 in total

Review 1.  Genetic causes of primary aldosteronism.

Authors:  Eric Seidel; Julia Schewe; Ute I Scholl
Journal:  Exp Mol Med       Date:  2019-11-06       Impact factor: 8.718

Review 2.  Clinical Translationality of KCNJ5 Mutation in Aldosterone Producing Adenoma.

Authors:  Takumi Kitamoto; Tetsuo Nishikawa
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

3.  Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.

Authors:  Kelly De Sousa; Sheerazed Boulkroun; Stéphanie Baron; Kazutaka Nanba; Maxime Wack; William E Rainey; Angélique Rocha; Isabelle Giscos-Douriez; Tchao Meatchi; Laurence Amar; Simon Travers; Fabio L Fernandes-Rosa; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2020-03-02       Impact factor: 10.190

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.